Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2023, titled "Press Release regarding grant of USFDA approval for Rocuronium Bromide Injection to our Subsidiary Caplin Steriles Limited. ".
Press Release Mar 03 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Feb 14 2023
- Press Release Aug 22 2022
- Press Release Sep 24 2021
- Press Release Sep 08 2021
- Press Release Aug 17 2021
Later from Caplin Point Laboratories
- Press Release Mar 08 2023
- Press Release May 12 2023
- Press Release Jun 01 2023
- Press Release Jun 12 2023
- Press Release Aug 11 2023
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories